Amphastar Pharmaceuticals Inc (AMPH) Q3 2026 Earnings Call Highlights: Record Revenue of $207. ...
Amphastar Pharmaceuticals Inc (AMPH) posts record quarterly sales driven by Baximi and Primatene Mist, but gross margin slips to 48% as IMS remediation costs and pricing headwinds weigh on results. Related Stocks: AMPH ,